Vision Medicines Announces Exclusive Worldwide Licensing Agreement with Case Western Reserve University for Stargardt Disease Drug Candidate
BOSTON--(BUSINESS WIRE)--Vision Medicines announces exclusive worldwide license from Case Western Reserve University for drug candidate for Stargardt disease. Stargardt leads to legal blindness.
